SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 56.06 |
| Enterprise Value ($M) | 20.29 |
| Book Value ($M) | -8.21 |
| Book Value / Share | -1.80 |
| Price / Book | -6.83 |
| NCAV ($M) | -14.38 |
| NCAV / Share | -3.15 |
| Price / NCAV | -3.90 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -0.28 |
| Return on Equity (ROE) | -0.85 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.81 |
| Current Ratio | 0.90 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 60.85 |
| Assets | 67.03 |
| Liabilities | 75.24 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 63.91 |
| Operating Income | -24.48 |
| Net Income | -22.93 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -22.43 |
| Cash from Investing | -0.51 |
| Cash from Financing | 25.98 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Point72 Asset Management, L.P. | 1.40 | -67.68 | |
| 13G/A | Biotechnology Value Fund L P | 9.99 | 35.19 | |
| 13G/A | Nantahala Capital Management, LLC | 1.70 | -64.58 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 145,577 | 522,807 | 27.85 | |
| 14,823 | 56,449 | 26.26 | |
| 482,013 | 1,749,406 | 27.55 | |
| 706,290 | 792,063 | 89.17 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CASI – CASI Pharmaceuticals, Inc. | CDIO – Cardio Diagnostics Holdings, Inc. |
| CDMO – Avid Bioservices, Inc. | CDXC – ChromaDex Corporation |
| CELU – Celularity Inc. |
Financial data and stock pages provided by
Fintel.io